Xiyanping allergic reaction, most commonly erythema and pruritus around the injection site, but more rarely anaphylactic reactions may occur, which can be life-threatening. Also, andrographolide and related derivatives are known to be abortifacient, making xiyanping unsuitable for use in pregnant women. Xiyanping Xiyanping (喜炎平) is an anti-inflammatory and antiviral preparation developed and licensed for use in China. It is a semi-synthetic injectable product derived from the active component of the plant "Andrographis paniculata" (Chuan Xin Lian, 穿心蓮), which is used in Traditional Chinese medicine. Xiyanping is primarily composed of 9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate. It is used mainly in the treatment
Suicide and Life-Threatening Behavior the category "Psychology Multidisciplinary" and 60th out of 117 journals in the category "Psychiatry (Social Science)". Suicide and Life-Threatening Behavior Suicide and Life-Threatening Behavior is a peer-reviewed academic journal published six times per year by Wiley-Blackwell on behalf of the American Association of Suicidology. The journal was established in 1971 by Edwin S. Shneidman. Its current editor-in-chief is Thomas Joiner (Florida State University). The journal covers scientific research on suicidal and other life-threatening behaviors, including risk factors for suicide, ethical issues in intervention research, and mental health needs of those bereaved by suicide. According to the "Journal Citation Reports", the